Franz Recker
103 works · 9,336 citations · h-index 23
Top works
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- Prostate-Cancer Mortality at 11 Years of Follow-up
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- LAPAROSCOPIC NEPHRECTOMY: THE EXPERIENCE OF THE LAPAROSCOPY WORKING GROUP OF THE GERMAN UROLOGIC ASSOCIATION
- Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
- Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
- Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests
- In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL
- European Study of Prostate Cancer Screening — 23-Year Follow-up
- PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE
- Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen
- A (-5, -7) ProPSA Based Artificial Neural Network to Detect Prostate Cancer
- Effects of Lithotripsy on Rat Kidney
- Retroperitoneal laparoscopic nephropexy
- A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer ( ERSPC , Aarau)
- Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort
- A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations
- Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer
- Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer